Articles by Philippe Flandre

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

Fourati, Slim; Malet, Isabelle; Lambert, Sidonie; More

AIDS. 26(13):1619-1624, August 24th, 2012.

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002–2011 survey

Lambert-Niclot, Sidonie; Tubiana, Roland; Beaudoux, Céline; More

AIDS. 26(8):971-975, May 15th, 2012.

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136

Katlama, Christine; Valantin, Marc A; Algarte-Genin, Michele; More

AIDS. 24(15):2365-2374, September 24th, 2010.

Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets

Assoumou, Lambert; Cozzi-Lepri, Alessandro; Brun-Vézinet, Françoise; More

AIDS. 24(3):365-371, January 28th, 2010.

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

Delfraissy, Jean-François; Flandre, Philippe; Delaugerre, Constance; More

AIDS. 22(3):385-393, January 30th, 2008.

Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients

Vora, Samir; Marcelin, Anne-Geneviève; Günthard, Huldrych F; More

AIDS. 20(1):35-40, January 2nd, 2006.